Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 10, 2011Science Translational MedicineOpen Access

T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMichael KalosBLBruce L. LevineDPDavid L. Porter

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kalos et al. (2011) studied this question.

synapsesocial.com/papers/69d8d33013e0539d74bedafdhttps://doi.org/10.1126/scitranslmed.3002842
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.1989 · 1,588 citations
  2. 2CARs on Track in the Clinic2011 · 114 citations
  3. 3Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor2010 · 299 citations
  4. 4Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti- CD19 immunotoxins1988 · 227 citations
  5. 5Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo2009 · 1,201 citations